Acute Heart Failure

Dr Vu Hoang Vu proCardio 2025 - Safety of Rx Optimisation Post AHF Hospitalization

proCardio Asia Pacific

Safety of Rx Optimisation Post AHF Hospitalization

Dr Vu Hoang Vu

Dr Raja Ezman Faridz proCardio 2025 - The Importance of Early Diagnosis and Management of AHF

proCardio Asia Pacific

The Importance of Early Diagnosis and Management of AHF

Dr Raja Ezman Faridz

Dr David Sim procardio 2025 - Optimising GDMT Post AHF Discharge - APAC APSC Consensus Highlights

proCardio Asia Pacific

Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights

Dr David Sim

Dr Chung Lieh Hung procardio 2025 - Initiation of GDMT Therapy in Patients Discharged Post AHF - What are the Guardrails?

proCardio Asia Pacific

Initiation of GDMT Therapy in Patients Discharged Post AHF – What are the Guardrails?

Dr Chung-Lieh Hung

Speaker at a conference podium

proCardio Asia Pacific

NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan

Dr Shiro Ishihara

Human heart illustration. Text on the left reads: Strong-HF, Contemporary post-discharge management in heart-failure.

Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20150%20150'%3E%3C/svg%3E" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Prof Mebazaa, the principal investigator of STRONG-HF, giving a talk on his first-hand experience and insights on implementing the protocol.

STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure

Prof Alexandre Mebazaa

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Prof John Amerena

Laptop showing an illustration of doctors standing around a heart, discussing diagnosis and treatment for heart failure, on a grey banner background. Text to the left read "STRONG-HF; contemporary post-discharge management in heart failure

STRONG-HF Trial highlighting benefits of treatment optimisation

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20150%20150'%3E%3C/svg%3E" data-src="https://cardiothinklab.com/wp-content/uploads/2021/08/logo-icon-310x310-1-150x150.png" width="150" height="150">

Cardio ThinkLab

Dr-Jack-Tan_banner

proCardio Asia Pacific

APAC Heart Failure Gap Report

Dr Jack Tan

Dr Wenjuan Jiang

The rationale for the use of hs-cTn in the optimal management of ACS

Dr Jiang Wenjuan

CTL-Dr-Genis_E

What is the Peptide for Life initiative?

Dr Antoni Bayes-Genis

Load more articles

2800+ Healthcare Professionals have cardiac insights delivered to their inbox

Sign up to receive the latest updates via your email